Discovering a Novel Approach to Sustained Drug Delivery Through the Design and Manufacturing of Processable Prodrugs
Time: 2:00 pm
day: Conference Day One
Details:
- Our Technology: based on a discovery that drugs can be chemically engineered into controlled release pharmaceuticals without the use of polymers
- Preclinical to Clinical Translation: Our first product for DME & RVO
- Future Direction: dry AMD feasibility & preclinical POC of our glaucoma product concepts
